ライフサイエンスコーパス: hip

1 10(-20)), type 2 diabetes (P=2.8 x 10(-13)), hip/waist circumference in men (P=1.1 x 10(-9)), schizop

2 ypes (hip, ncases=3,498; knee, ncases=3,266; hip and/or knee, ncases=7,410; ncontrols=11,009).

3 rtile range, 0.57-2.34 years), there were 27 hip fractures in the alendronate group and 73 in the no-

4 knee OA, replication cohorts: 17 knee OA, 9 hip OA patients).

5 100 g/L within 3 days of surgery to repair a hip fracture, were eligible for enrolment.

6 .4 years, 1,603 women and 951 men suffered a hip fracture.

7 Sedentary time was measured using a hip-mounted accelerometer.

8 dentary time was objectively measured with a hip-mounted accelerometer.

9 -weight heparin for thromboprophylaxis after hip or knee arthroplasty.

10 rtment visits for elders up to 2 years after hip-fracture surgery, above and beyond the effects of us

11 e efficacy of alendronate to protect against hip fracture in older patients using glucocorticoids.

12 patients with a malfunctioning cobalt-alloy hip prosthesis.

13 lexion reflex) and the rhythmic, alternating hip flexor and extensor activities underlying locomotion

14 5 +/- 5.25 vs. 5.50 +/- 5.52; P < 0.001) and hip fractures (1.57 +/- 2.40 vs. 1.79 +/- 2.69; P = 0.00

15 controls 0.62 cm, 0.2 to 1.0, p=0.001), and hip circumference (adjusted difference vs community cont

16 [aHR], 1.39; 95% CI, 1.27-1.51; P < .05) and hip fracture (aHR, 1.43; 95% CI, 1.22-1.69; P < .05) bef

17 lassically described as pain in the back and hip with radiation in the leg along the distribution of

18 variation in bone mineral density (BMD) and hip bone geometry are associated with fracture risk.

19 The associations between risk factors and hip fracture were similar in strength across BMI strata.

20 Peak stance-phase knee and hip extension increased by 12 degrees and 8 degrees , re

21 cient for standing with independent knee and hip extension.

22 ods, we show differences between RA knee and hip FLS in the methylation of genes encoding biological

23 ressed genes are identified between knee and hip FLS using RNA-sequencing.

24 r walk time, knee and hip pain, and knee and hip function did not (P for all >/=.05).

25 ut improvement rates for walk time, knee and hip pain, and knee and hip function did not (P for all >

26 rgoing colectomy, hysterectomy, and knee and hip replacement procedures.

27 ntact and degraded cartilage of the knee and hip.

28 ignificantly increased risk for both MOF and hip fracture.

29 atic major osteoporotic fractures (MOFs) and hip fractures.

30 included the incidences of nonvertebral and hip fracture at the time of the primary analysis.

31 howed a smaller decrease in lumbar spine and hip bone mineral density but greater accumulation of lim

32 +/- 29% and -0.85% +/- 19% in the spine and hip, respectively (P < .001 vs placebo).

33 th greater BMD loss at both lumbar spine and hip.

34 easurements of height, weight, and waist and hip circumference taken.

35 (body mass index, height, weight, waist and hip circumference, waist-to-hip ratio).

36 common, particularly among older women, and hip fractures can be devastating.

37 82 mm; 'distorted', 4.402 +/- 1.098 mm; and 'hip patients' 8.083 +/- 4.653 mm; P < 0.001.

38 the most frequent finding after arthroscopic hip surgery in both asymptomatic and symptomatic patient

39 and symptomatic patients after arthroscopic hip surgery.

40 smaller decrease in bone mineral density at hip (mean change -0.10% [95% CI -0.29 to 0.09] vs -1.72%

41 Qualitative similarities between hip fracture trends in different countries suggests vari

42 ntre with a complaint of severe pain in both hip joints.

43 he D group reduced BMI, waist circumference, hip circumference, and body fat percentage more than did

44 whereas height, weight, waist circumference, hip circumference, fat mass, and fat-free mass were line

45 nt slip of the epiphysis, is the most common hip abnormality in adolescents and is a major cause of e

46 eriod for body mass index, body composition, hip circumference, resting energy expenditure, and respi

47 the optimal time window in which to conduct hip fracture surgery before the risk of complications in

48 rocircuits exist for motor pools controlling hip, ankle, and foot muscles, revealing a variable circu

49 al prednisolone is associated with decreased hip fracture risk and adverse effects.

50 pulmonary disease) and a surgical diagnosis (hip fracture treated with arthroplasty) in 2010.

51 al bisphosphonate therapy was started if DXA hip T scores were less than or equal to -2.5, 10-year ri

52 3000 N, or occurrence of first fracture (eg, hip, vertebral body, wrist).

53 rs or older initiating warfarin for elective hip or knee arthroplasty and was conducted at 6 US medic

54 Among patients undergoing elective hip or knee arthroplasty and treated with perioperative

55 male) and 5002 patients undergoing emergency hip fracture repair (mean [SD] age, 79.5 [11.8] years; 1

56 resection and patients undergoing emergency hip fracture repair successfully altered processes of ca

57 resection and patients undergoing emergency hip fracture repair.

58 athletes: intraarticular and extraarticular hip impingement syndromes, labral and cartilage disease,

59 Following hip fracture surgery (n = 319,804), 10,931 patients (3.4

60 rquartile range [IQR], 17-48 days) following hip arthroplasty vs 42 days (IQR, 21-114 days) following

61 ge, and 1, 3, 6, 12, 18, 24 months following hip fracture.

62 teoporotic fractures: 1.08 (1.00, 1.06); for hip fractures: 1.06 (1.02, 1.12) per z score].

63 rthroplasty (HR, 3.79; 95% CI, 3.21-4.47 for hip replacement; HR, 2.68; 95% CI, 2.10-3.42 for knee re

64 5% confidence interval (CI): 1.18, 1.60) for hip fracture, as compared with women with BMI 22-24.9; a

65 trated a higher risk of mortality (1.82% for hip fracture surgery vs 0.31% for elective THR; absolute

66 major postoperative complications (5.88% for hip fracture surgery vs 2.34% for elective THR; absolute

67 teoporotic fractures: 0.90 (0.83, 0.96); for hip fractures: 0.85 (0.81, 0.89) per z score of dietary

68 F, 1.15; 95% CI, 1.04-1.26; P < .05; aHR for hip fracture, 1.24; 95% CI, 1.05-1.47; P < .05) were eac

69 F, 1.43; 95% CI, 1.27-1.60; P < .05; aHR for hip fracture, 1.48; 95% CI, 1.18-1.85; P < .05), antipsy

70 F, 1.43; 95% CI, 1.15-1.77; P < .05; aHR for hip fracture, 2.14; 95% CI, 1.52-3.02; P < .05), and ben

71 Hazard ratios for hip fracture and associated 95% confidence intervals wer

72 ic acid, or denosumab to reduce the risk for hip and vertebral fractures in women who have known oste

73 followed for fracture, the absolute risk for hip fracture at 10 years was 20.4 events per 1000 patien

74 less than or equal to -2.5, 10-year risk for hip fracture was greater than 3% (World Health Organizat

75 ip biomechanics and discusses strategies for hip imaging modalities such as radiography, ultrasonogra

76 k estimates for AF tended to be stronger for hip circumference than for waist circumference and for f

77 Although wait times for hip fracture surgery have been linked to mortality and a

78 rtebral fracture (proximal humerus, forearm, hip) in adult kidney transplant recipients between 1994

79 stortion' due to susceptibility effects from hip prostheses.

80 ose receiving tenofovir disoproxil fumarate (hip -0.29% [95% CI -0.55 to -0.03] vs -2.16% [-2.53 to -

81 dently to high-quality female dance: greater hip swing, more asymmetric movements of the thighs, and

82 the risk factor responsible for the greatest hip fracture burden (7.5%, 95% CI 5.2-9.7) followed by p

83 ndisplaced hip fractures and 96 did not have hip fractures.

84 of high-resolution mSEM images of the human hip.

85 enuation obtained from imaging ex vivo human hip cartilage correlates with the glycosaminoglycan cont

86 with metal implants (either dental implants, hip prostheses, shoulder prostheses, or pedicle screws)

87 Increased adiposity in hip OA patients is associated with altered subchondral b

88 ee pain (77.1% [95% CI, 73.5%-80.7%]) and in hip function (79.2% [95% CI, 75.3%-83.1%]).

89 n such patients, romosozumab led to gains in hip BMD that were not observed with teriparatide.

90 related well with reduced muscle strength in hip and knee flexors and extensors.

91 fferentiation of osteonecrosis from TBMES in hip and knee joints.

92 ident MOF, 1579 (2.3%) sustained an incident hip fracture, and 8998 (13.1%) died.

93 24 (3.5%) participants developed an incident hip fracture, of whom 413 (5.3%) died as a result.

94 antify the burden of disease due to incident hip fracture using DALYs in prospective cohorts in the C

95 The primary outcome was incident hip fracture.

96 amined were other secondary events including hip fractures, congestive heart failure, angina, falls,

97 AF risk and height, weight, body mass index, hip and waist circumference, waist-to-hip ratio, and bio

98 noma but 2 months later developed a new left hip soft tissue nodule.

99 Results Twenty-two patients had nondisplaced hip fractures and 96 did not have hip fractures.

100 cium images in the detection of nondisplaced hip fractures and to assess whether obtaining these imag

101 hondrocyte repertoire of lncRNAs from normal hip cartilage donated by neck of femur fracture patients

102 Subchondral bone from over-weight/obese hip OA patients exhibited reduced trabecular thickness,

103 imated the 10-year risk of MOF by 29% and of hip fracture by 51% for those with depression.

104 osity on the architecture and composition of hip OA subchondral bone, and to examine the pathological

105 months) of intervention models consisting of hip fracture-specific care in conjunction with managemen

106 Evaluation of hip tissue by 16S rRNA gene polymerase chain reaction an

107 ) and falls, 10-year cumulative incidence of hip fracture alone, and nonvertebral fracture incidence

108 The 10-year cumulative incidence of hip fracture in all recipients was 1.7% (>/=3% defined a

109 183), but screening reduced the incidence of hip fractures (0.72, 0.59-0.89, p=0.002).

110 iation between dietary patterns, measures of hip bone geometry, and subsequent fracture risk are scar

111 est densitometric or geometric predictors of hip failure load.

112 FRAX underestimated the 10-year risk of hip fracture by 57% for use of selective serotonin reupt

113 ndronate was associated with a lower risk of hip fracture in a multivariable-adjusted Cox model (haza

114 ssociated with a significantly lower risk of hip fracture over a median of 1.32 years.

115 7 patients [10.6%]; P=0.04), and the risk of hip fracture was lower by 38% (41 of 2046 patients [2.0%

116 ed in women identified to be at high risk of hip fracture, according to the FRAX 10-year hip fracture

117 I; weight (kg)/height (m)(2)) lowers risk of hip fracture.

118 s (generic) and denosumab reduce the risk of hip, nonvertebral, and vertebral fractures; bisphosphona

119 OC) intravenous antibiotics for treatment of hip or knee PJI.

120 The phantom consisted of 2 types of hip prostheses in a solution of (18)F-FDG and water.

121 This proof-of-concept study focused on hip fractures, but use of record linkage techniques to v

122 This review article provides an overview on hip biomechanics and discusses strategies for hip imagin

123 ortions of participants who had at least one hip fracture, any clinical fracture, or mortality; and t

124 nts with severe knee or disability (633), or hip pain or disability (500) at baseline, approximately

125 tio (ORstavudine, 1.30; 95% CI, .85-1.96) or hip circumference (ORstavudine, 1.40; 95% CI, .93-2.11).

126 score of -2.5 or less, a history of spine or hip fracture, or a Fracture Risk Assessment Tool (FRAX)

127 ing and the tapered junctions of orthopaedic hip implants are known to differ and the debris generate

128 ality used to evaluate patients with painful hip joints.

129 the inclusion criteria; 13.6% had a parental hip fracture diagnosis in administrative data during an

130 onger interval between BMD test and parental hip fracture diagnosis.

131 Agreement between parental hip fracture from offspring reports and diagnoses in adm

132 with BMD tests and self-reports of parental hip fracture between 2006 and 2014.

133 the validity of offspring-reported parental hip fracture in a unique bone mineral density (BMD) regi

134 rrelation between the combined OA phenotype (hip and/or knee) and lumbar spine BMD (rg=0.18, P = 2.23

135 arcOGEN consortium for three OA phenotypes (hip, ncases=3,498; knee, ncases=3,266; hip and/or knee,

136 patients receiving colon, rectal, or primary hip or knee surgery, 18 years of age or older, who were

137 mmon set of spinal cord neurons that produce hip flexion during flexion reflex, locomotion, and scrat

138 data points on a typical archived prosthetic hip scan.

139 th policies should be strengthened to reduce hip fracture incidence and mortality.

140 feasible, and could be effective in reducing hip fractures.

141 partment with severe acute pain in the right hip and right leg which was aggravated by limb movement.

142 ale patient presented with pain in the right hip for 5 days, following a slip and fall accident while

143 longitudinal section obtained over the right hip joint region.

144 ep lasted longer than the left and the right hip was higher than the left; when the right H-reflex wa

145 Rose hip fruit, which contains high concentration of caroteno

146 hibiscus, mate, peppermint, rooibos and rose hip) cover the most important matrices (flower, fruit, s

147 c oils, pressed at low temperature from rose hip seeds, were characterised for their composition, qua

148 dentify and quantify the carotenoids in rose hip fruit of four rose species, including both unsaponif

149 ion, including the carotenoid esters in rose hip fruit were identified and quantified.

150 This work reveals the potential of rose hip fruit to be utilized as a healthy dietary material a

151 treated for presumed culture-negative septic hip arthritis despite having prior postantibiotic diarrh

152 ferent countries show variations of a shared hip fracture epidemic.

153 e the association between BMI and subsequent hip fracture according to sex and age and 2) to explore

154 egy, 12.8% of postmenopausal women sustained hip fractures in their remaining life (no screening, 18.

155 us was reduced or eliminated during the swim hip extensor phase.

156 turtles if the tap occurred during the swim hip extensor phase.

157 537 outpatients with symptomatic hip or knee osteoarthritis.

158 In addition, the hip flexor nerve response to an electrical foot stimulus

159 density was measured at lumbar spine and the hip.

160 one mineral density and bone strength at the hip and spine.

161 osteoporosis by DXA (T score </=-2.5 at the hip or spine), with 82.8% sensitivity in 24 of 29 patien

162 t potential fracture risk, especially at the hip, spine and wrist.

163 dividuals at the lumbar spine but not at the hip.

164 ilograms and was ~35 centimeters tall at the hip.

165 Considering both the hip and spine, the classification of patients at high ri

166 The spinal cord can generate the hip flexor nerve activity underlying leg withdrawal (fle

167 Similar trends were observed in the hip and femoral neck.

168 magnetic resonance (MR) arthrography of the hip 1 year after arthroscopic treatment of femoroacetabu

169 acements for end-stage osteoarthritis of the hip and knee are cost-effective and demonstrate signific

170 diagnosed with transient osteoporosis of the hip and one with a stress fracture of the sacral bone.

171 sessment of the mechanical competence of the hip and to demonstrate the reproducibility of the tool.

172 Living inhabitants of the hip bone (e.g. osteocytes) are visible in their local ex

173 l sulcus, labral defects, and defects of the hip capsule in several anatomic positions (anterior to p

174 Defects of the hip capsule were more common in asymptomatic patients (7

175 ng, the authors present abnormalities of the hip joint and the surrounding soft tissues that can occu

176 d cartilage disease, microinstability of the hip, myotendinous injuries, and athletic pubalgia.

177 viduals homozygous for rs532464664 had their hip replacement operation 13.5 years and 4.9 years earli

178 lity-adjusted life-years (DALYs) lost due to hip fractures using real-life follow-up cohort data.

179 s (27 per 1000 individuals) were lost due to hip fractures, 1230 (20.6%) of which were in the group a

180 ars at baseline in 1994-2003) with regard to hip fracture.

181 stimate mechanical parameters that relate to hip fracture resistance by using MR images.

182 s index (BMI), waist circumference, waist to hip ratio and fasting insulin.

183 Subcutaneous abdominal fat and waist to hip ratio decreased significantly more in the high-volum

184 MI risk score (ie, blood pressure, waist to hip ratio, hemoglobin A1c level, and the ratio of apolip

185 body fat distribution, with a lower waist-to-hip ratio (-0.004 cm [95% CI -0.005, -0.003] 50% vs. 50%

186 ] 50% vs. 50%; P = 2E-6) and higher waist-to-hip ratio (0.0013 [0.0003, 0.0024] 50% vs. 50%; P = 0.01

187 bodyweight (1.03 kg, 0.24 to 1.82), waist-to-hip ratio (0.006, 0.003 to 0.010), and an odds ratio for

188 tiles vs highest tertile of mAHEI), waist-to-hip ratio (1.44, 1.27-1.64 for highest vs lowest tertile

189 95%CI: 1.39-1.99; Ptrend < 0.0001), waist-to-hip ratio (HR = 1.58, 95%CI: 1.31-1.91; Ptrend < 0.0001)

190 For women, only waist-to-hip ratio (HR for highest versus lowest fifth = 1.33, 95

191 ted after additional adjustment for waist-to-hip ratio (ORHIV, 1.29; 95% CI, .95-1.76).

192 er additional adjustment for either waist-to-hip ratio (ORstavudine, 1.30; 95% CI, .85-1.96) or hip c

193 ation of a polygenic risk score for waist-to-hip ratio (WHR) adjusted for body mass index (BMI), a me

194 ides (TG), fasting insulin (FI) and waist-to-hip ratio (WHR) in 4,721 individuals from the Northern F

195 diagnosis body mass index (BMI) and waist-to-hip ratio (WHR) with late all-cause mortality and late r

196 en combined measurements of BMI and waist-to-hip ratio (WHR) with mortality and incident coronary art

197 ndex (BMI), height and BMI-adjusted waist-to-hip ratio (WHR).

198 low-density lipoprotein 31.4%; and waist-to-hip ratio 29.7%.

199 ), waist circumference (WC), or the waist-to-hip ratio adjusted for BMI (WHRBMI), the following 4 gen

200 0.086; P = 8.1 x 10(-7)) but lower waist-to-hip ratio adjusted for BMI, a marker of abdominal fat di

201 predisposition score including the waist-to-hip ratio adjusted for BMI-associated single nucleotide

202 associations of central adiposity (waist-to-hip ratio adjusted for body mass index [WHRadjBMI]) and

203 A genetic predisposition to higher waist-to-hip ratio adjusted for body mass index was associated wi

204 xes of JNK signaling activity, IL6, waist-to-hip ratio and hsCRP.

205 ease in height, a 0.003 increase in waist-to-hip ratio and increase in BMI by 0.14 kg/m(2) for each M

206 s, including large meta-analysis of waist-to-hip ratio and waist circumference adjusted for body mass

207 measured as waist circumference and waist-to-hip ratio both adjusted for BMI.

208 ce interval (CI): 1.05 to 1.12] for waist-to-hip ratio to 1.37 [95% CI: 1.33 to 1.42] for lean body m

209 )=89%) and per 0.1-unit increase in waist-to-hip ratio was 1.29 (95% confidence interval, 1.13-1.47;

210 ], height, waist circumference, and waist-to-hip ratio) and body fat composition (total body fat perc

211 eight, waist and hip circumference, waist-to-hip ratio).

212 cose concentration, bodyweight, and waist-to-hip ratio, and an increased risk of type 2 diabetes.

213 cose concentration, bodyweight, and waist-to-hip ratio, and an increased risk of type 2 diabetes.

214 index, hip and waist circumference, waist-to-hip ratio, and bioelectrical impedance-derived measures

215 tivity, and the interaction of age, waist-to-hip ratio, and length of the Barrett's oesophagus segmen

216 association studies (GWAS) for BMI, waist-to-hip ratio, and other adiposity traits have identified mo

217 ral adiposity (waist circumference, waist-to-hip ratio, and waist-to-height ratio) and hypertension w

218 HbA1c, fasting insulin, bodyweight, waist-to-hip ratio, BMI, and risk of type 2 diabetes, using a sta

219 , included age, fS-pIGFBP-1, S-ALT, waist-to-hip ratio, fP-Glucose and fS-Insulin (adjusted R(2) = 0.

220 f abdominal obesity, as measured by waist-to-hip ratio, have distinct biological backgrounds.

221 Children with psoriasis had higher waist-to-hip ratios (0.85 vs. 0.80; P < 0.002) and insulin resist

222 K10K, testing for associations with waist-to-hip ratios.

223 Total hip replacement is a commonly performed orthopedic proce

224 tion of male patients ranged from 37% (total hip replacement) to 77% (abdominal aortic aneurysm repai

225 irty-day readmission to hospital after total hip arthroplasty (THA) has significant direct costs and

226 f young age and risk of revision after total hip or knee replacement.

227 th increased risk of readmission after total hip replacement: being older than 71 years (OR, 1.83; 95

228 have been used in dental implants and total hip arthroplasty due to their excellent biocompatibility

229 tion ($63117 vs $21325; P < .001), and total hip replacement ($41354 vs $19028; P < .001).

230 , pulmonary resection (n = 91758), and total hip replacement (n = 307399) between 2009 and 2012.

231 e total-body radius, lumbar spine, and total hip were observed between subjects who received the dair

232 by 16.5% at the lumbar spine, 7.4% at total hip, 7.1% at femoral neck, and 2.3% at one-third radius.

233 by 21.7% at the lumbar spine, 9.2% at total hip, 9.0% at femoral neck, and 2.7% at the one-third rad

234 with serial bone density examinations, total hip BMD increased transiently in women with parathyroide

235 zation (range: 61% for TURP to 88% for total hip arthroplasty), and are thus missed by the ProPublica

236 For total hip replacement, 10-year implant survival rate was 95.6%

237 g revision surgery in patients who had total hip replacement or total knee replacement over the age o

238 ean percentage change from baseline in total hip areal BMD was 2.6% (95% CI 2.2 to 3.0) in the romoso

239 f dislocation and aseptic loosening in total hip arthroplasty (THA).

240 lusion: Treatment-related increases in total hip BMD are associated with reduced fracture risk compar

241 y, women with a detectable decrease in total hip BMD compared with stable BMD had an absolute increas

242 in women with a detectable increase in total hip BMD was 1.3% (CI, 0.4% to 2.2%) and 2.6% (CI, 0.7% t

243 nterquartile range) percent decline in total hip BMD was greater in those with high- compared to low-

244 Clinical improvement projects included total hip and knee joint replacement, hospitalist laboratory u

245 allenges the increasing trend for more total hip replacements and total knee replacements to be done

246 med a genome-wide association study of total hip replacements, based on variants identified through w

247 97%, I(2): 0%; n = 5) but no effect on total hip (TH), femoral neck (FN), or total body BMD or bone b

248 r surgery (fracture groups, n = 33) or total hip arthroplasty (nonfracture groups, n = 17).

249 218940 patients at 1056 hospitals), or total hip replacement (THR) (231774 patients at 1831 hospitals

250 strongly associate with osteoarthritis total hip replacement: a missense variant, c.1141G>C (p.Asp369

251 underwent future targeted procedures (total hip replacement, total knee replacements) or nontargeted

252 ral density (BMD) at the lumbar spine, total hip, femoral neck, and one-third radius.

253 ]), as did bone mineral density at the total hip (grams per square centimeter; 1.010 to 0.996 [1% dec

254 ual-energy x-ray absorptiometry at the total hip through month 12 (mean of months 6 and 12), which us

255 al BMD T score of -2.5 or lower at the total hip, femoral neck, or lumbar spine; and a history of fra

256 characteristics of patients undergoing total hip replacement were abstracted.

257 fied 63 158 patients who had undergone total hip replacement and 54 276 who had total knee replacemen

258 ce Research Datalink who had undergone total hip replacement or total knee replacement.

259 CT for suspicion of a nondisplaced traumatic hip fracture.

260 for the detection of nondisplaced traumatic hip fractures and improved diagnostic confidence in the

261 rospective cohort study of adults undergoing hip fracture surgery between April 1, 2009, and March 31

262 Among adults undergoing hip fracture surgery, increased wait time was associated

263 0-2.62]; P < .001) among patients undergoing hip fracture surgery.

264 Secondary outcomes included new vertebral, hip, and non-vertebral fractures as well as bone mineral

265 BMP-9 was associated negatively with Waist hip ratio (WHR), fasting blood glucose (FBG), 2-hour blo

266 asured by waist circumference (WC) and waist-hip ratio (WHR), have been previously identified, primar

267 y mass index, waist circumference, and waist-hip ratio gave RRs of 1.22 (95% confidence interval [CI]

268 ng height, weight, body-mass index and waist-hip ratio.

269 schizophrenia, bipolar disorder, BMI, waist-hip-ratio, insulin resistance and height, as well as gen

270 with higher BMI, waist circumference, waist-hip ratio, alanine transaminase, white blood cell count

271 body mass index, waist circumference, waist-hip ratio, and 10-year weight change on the risk of deve

272 tatus, triglycerides, type 2 diabetes, waist-hip ratio, attention deficit hyperactivity disorder, bip

273 tatus, triglycerides, type 2 diabetes, waist-hip ratio, childhood cognitive ability, neuroticism, bip

274 ssed in adipose and is associated with waist-hip ratio adjusted for BMI.

275 ndex in 152,893 men and 171,977 women, waist-hip ratio in 93,480 men and 116,741 women).

276 Body mass index and WHR as waist/hip circumference (in centimeters).

277 n epicardial fat, waist circumference, waist/hip ratio, and body mass index.

278 mference, 1.11 (95% CI, 1.08-1.14) for waist/hip ratio, and 1.22 (95% CI, 1.17-1.27) for body mass in

279 st Study found that obesity (increased waist/hip ratio) was linked to an increased incidence of TNBC

280 evidence of ID for handgrip strength, waist/hip ratio, and visual and auditory acuity (ID between -2

281 y mass index, waist circumference, and waist:hip ratio).

282 ed by increased waist circumference or waist:hip ratio (WHR), is associated with increased cardiovasc

283 ocyte populations, compared to normal weight hip OA patients.

284 gen alpha1/alpha2, compared to normal-weight hip OA patients.

285 s were found between obese and normal-weight hip OA patients.

286 Most affected muscle groups were hip and knee flexors and extensors on strength testing.

287 loped incident fractures, including 198 with hip fractures.

288 identify loci significantly associated with hip dysplasia, elbow dysplasia, idiopathic epilepsy, lym

289 gnostic step in the work-up of athletes with hip pain.

290 -reported physical function in patients with hip and knee osteoarthritis.

291 tients with hip prostheses, 11 patients with hip and knee prostheses, and 1 patient with a femoral pr

292 Among 42230 patients with hip fracture (mean [SD] age, 80.1 years [10.7], 70.5% wo

293 -0.86; P = .03), whereas among patients with hip fracture, implementation was associated with increas

294 5% CI, 0.45-0.99, P = .05) for patients with hip fracture.

295 we investigated whether obese patients with hip OA exhibited differential pro-inflammatory cytokine

296 al-weight or over-weight/obese patients with hip OA.

297 (68)Ga-PSMA) PET/CT scans of 7 patients with hip prostheses were scored by 2 experienced nuclear medi

298 s with shoulder prostheses, 14 patients with hip prostheses, 11 patients with hip and knee prostheses

299 3 or 6 months of treatment for subjects with hip or knee debride and retain strategies, respectively.

300 hip fracture, according to the FRAX 10-year hip fracture probability.